Intravenous immune globulin (IVIG) is an expensive blood product licensed in Canada for the treatment of limited medical conditions, primarily primary and secondary immunodeficiency diseases. IVIG is derived from human plasma collected from multiple Canadian blood donors or purchased from the United States and Europe. It is subject to periodic shortages and carries the risk of adverse events.

The Manitoba Blood Programs Office, which is part of the Office of Provincial Renal, Transplant and Transfusion Services in partnership with Diagnostic Services of Manitoba (DSM)-Transfusion Medicine are undertaking a provincial IVIG/SCIG Utilization Project. Prospective utilization data will be collected through the recently developed IVIG/SCIG Physician Request Form. All in hospital and out-patient orders for IVIG/SCIG will require a completed form prior to issue of the product. The goal of the program is to evaluate prescribing patterns of IVIG/SCIG and assess ongoing demand for this blood product.

Physician Request Forms – Click below links:

Initial Treatment Form – Intravenous Immune Globulin (IVIG) Subcutaneous Immune Globulin (SCIG) Physician Request Form

Follow Up Form – Intravenous Immune Globulin (IVIG) Subcutaneous Immune Globulin (SCIG) Physician Request Form

Approved Prescribers List – Updated August 21, 2017

Click here to be re-directed to learn further information on IVIG Utilization Guidelines, FAQ and an Information Presentation.